Swiss biopharma company GeNeuro has announced tgat its two-year Phase IIb study of temelimab in multiple sclerosis (MS) confirmed the results from a previous 48-week CHANGE-MS trial where the drug...
12 March 2019 News
4 March 2019 Comment
The global burden of Parkinson's disease is increasing over time due to the increasing numbers of older people.
28 February 2019 Comment
Depending on the outcome of Brexit, thousands of extra deaths from cardiovascular disease and strokes may occur in Britain over the next decade, a study in the British Medical Journal...
26 February 2019 Comment
UCB’s £2.5m genomic research programme with Epilepsy Society has the potential to transform the diagnosis and treatment of epilepsy patients
20 February 2019 News
The University of Dundee Drug Discovery Unit has announced it has entered into a drug development partnership focused on tau pathology with Japanese pharmaceutical giant Takeda.
15 February 2019 News
US precision medicine company Sarepta Therapeutics has announced the US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for its Duchenne muscular dystrophy (DMD) drug Golodirsen...
15 February 2019
Gene therapy company Passage Bio has launched in the US with $115.5m series A funding to develop AAV-delivered therapies for the treatment of rare monogenic central nervous system (CNS) disorders.
14 February 2019 News
South Korea-based SK Biopharmaceuticals and Swiss Arvelle Therapeutics have signed an exclusive licensing agreement to develop and commercialise SK Biopharmaceuticals’ cenobamate in Europe.
13 February 2019 News
Charity industry partnership Dementia Consortium has announced that pharmaceutical companies, Johnson & Johnson Innovation, Takeda and research organisation Evotec have joined its drug discovery collaboration for neurodegenerative diseases.
22 January 2019 News
A new study by the University of Eastern Finland has found that use of antiepileptic drugs can lead to more hospital days for people living with Alzheimer’s disease.